Sultan bin Turki Al Sedairy

Sultan Al-Sedairy (Arabic: سلطان بن تركي بن ناصر السديري‎) is a Saudi scientist born in 1955 in Riyadh, Saudi Arabia. He currently holds the following positions: Research Centre executive director (King Faisal Specialist Hospital and Research Centre, since 1996), chief executive director (King Salman Center for Disability Research, since 2004), and professor, College of Medicine (Alfaisal University, since 2011).

Sultan bin Turki bin Nasser Al-Sedairy
A photo of Al-Sedairy
Born1955
Riyadh, Saudi Arabia
NationalitySaudi
Alma materColumbia University, New York
OccupationExecutive Director of the King Faisal Specialist Hospital and Research Centre and Chief Executive Director of the King Salman Center for Disability Research

Education

Al-Sedairy received his Bachelor of Science degree in Biology/Chemistry in 1979 from the University of Puget Sound (Tacoma, Washington). He received his diploma in Medical Technology in 1981 from the Cleveland Clinic Education Foundation (Cleveland, Ohio). He completed his MA in Pathology in 1982, his MPhil in 1984, and his PhD in 1987 (Pathobiology, with focus on tumor immunology), Thesis: Human Tumor Antigens Identified with Monoclonal Antibodies[1][2] all from Columbia University (New York). His post-doctoral fellowship was completed under the supervision of Prof. H. Vogel in 1987 (March - October) at the Department of Pathology, College of Physicians and Surgeons (Columbia University).

Leadership

National

Member, Biotechnology Committee of the King Abdulaziz City for Science and Technology
Member, Kingdom's Experts' Council in the field of Medical Science and Technology
Member, Oversight Committee for the National Strategy for Science and Technology and Innovation
Member, Technology Advisory Council, Saudi Technology Development and Investment Company (TAQNIA)

International

Vice President, International Network for Cancer Treatment and Research
Member, Governing Council, International Network for Cancer Treatment and Research
Member of the Tumour Biology Committee, International Union Against Cancer
Member of the Board of Trustees, Dubai Harvard Foundation
Member of the Scientific Advisory Committee, Dubai Harvard Foundation
Member of the Scientific Committee, InNaBioSanté Foundation
Member of the Executive Committee, International Cancer Genome Consortium
Member of the International Scientific Steering Committee, International Cancer Genome Consortium
Member of the Executive Committee, International Rare Diseases Research Consortium
Member of the Advisory Board, KACST-UCSD Joint Center for Excellence in Nanomedicine & Engineering, University of California, San Diego, USA
Fellow, Royal Society of Medicine
Member of the Board of Directors, Taqnia International

Research

Al-Sedairy's research interest is in tumor and transplantation immunology and has published over 150 full-length papers and meeting abstracts. He is a Visiting Research Scientist at the Transplantation Research Centre at Children's Hospital at Harvard Medical School (Boston). He chairs the Research Advisory Council at KFSH&RC and helped establish local guidelines for medical research pertaining to scientific and ethical values. He supports increased awareness to the benefits of healthcare research and biotechnology[3] and towards ensuring the availability of resources and opportunities for the proliferation of research.[4][5]

Gender and Disability Issues

Al-Sedairy has helped advance several gender and disability-related initiatives. Some of these include the establishment of a national network of female Saudi scientists,[6] the establishment of a national newborn screening program,[7][8] and initiatives for the benefit of people with learning difficulties.[9][10][11]

gollark: Impossible.
gollark: ```Shh that didnt work``````i suck ```Inspiring and helpful commit messages.
gollark: <@173511059582222336> Is there some process for getting it to start or did you only test it on conversiony stuff?
gollark: I ran the node software but it appears to not actually create any tables in the DB.
gollark: Well, looks like Alpine Linux only has node 8 anyway, so I don't need `n` to downgrade, yay...

References
  1. Human Tumor Antigens Identified with Monoclonal Antibodies. Retrieved 2 September 2012.
  2. "Human Tumor Antigens Identified with Monoclonal Antibodies". Retrieved 2 September 2012.
  3. "Special Briefing" (PDF). Retrieved 2 September 2012.
  4. "Cutting edge research defines a hospital's status". Retrieved 31 August 2012.
  5. "KFSH&RC offered support to King Hamad Research Center in Bahrain" (PDF). Retrieved 31 August 2012.
  6. "Yasmin Altwaijri: Mother, wife and scientist". Retrieved 2 September 2012.
  7. "Medics, paramedics get training to screen newborns". Retrieved 2 September 2012.
  8. "Newborns being screened for 16 diseases". Retrieved 2 September 2012.
  9. "Salman Center for Disability Research, McGraw-Hill forge tie-up". Retrieved 2 September 2012.
  10. "PSCDR, McGraw-Hill sign MoU to develop educational programs". Retrieved 2 September 2012.
  11. "Addressing the Challenges of the Transition to College for the Disabled". Retrieved 2 September 2012.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.